Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Weishi Li is a partner in the firm's Life Sciences Transactions Practice. Her practice focuses on transactional matters for life sciences clients. She has extensive experience assisting Western and Chinese life sciences companies in structuring and negotiating cross-border commercial, corporate, and partnering transactions involving China, including strategic collaborations, joint ventures, licensing, acquisitions, co-promotion, and distribution arrangements. As a registered U.S. patent attorney with a Ph.D. in microbiology and substantial food and drug regulatory experience, Ms. Li has a deep understanding of the complex issues confronting the industry and is well-versed in helping clients tackling such issues.

  • China Business Law Journal, Greater China: A-List Top 100 Lawyers (2016)  
  • Chambers Asia-Pacific, China: Life Sciences (International Firms, Band 1) (2012-2019)   
  • Chambers Global, China: Global-Wide: Life Sciences (2014-2016)
  • Asia IP Experts, Licensing & Franchise; Pharma & Biotech (2014, 2017)    
  • The International Who's Who of Life Sciences Lawyers (2011-2015)
  • IAM Patent 1000, The World's Leading Patent & Technology Licensing Lawyers
  • IAM Licensing 250, The World's Leading Patent & Technology Licensing Lawyers